"
Team:Paris Bettencourt/Project/Overview
From 2013.igem.org
Ewintermute (Talk | contribs) |
|||
| Line 66: | Line 66: | ||
</div> | </div> | ||
<div class="rightparagraph"> | <div class="rightparagraph"> | ||
| - | <p | + | <p> |
| - | + | To defeat tuberculosis, we need new biotechnology. Our work will add 4 new tools to the anti-TB medical armamentarium. <b>Detect</b> - A CRISPR-based biosensor delivered by phage and sequence-specific for antibiotic resistance. <b>Target</b> - An E. coli model hosting an essential mycobacterial metabolic pathway that could simplfy drug screening. <b>Infiltrate</b> - A E. coli strain capable of entering infected macrophages and lysing mycobacteria. <b>Sabotage</b> - A non-lytic phage that spreads horizontally in a bacterial population and expresses an siRNA to knock down antibiotic resistance. | |
| - | + | </p> | |
</div> | </div> | ||
<div style="clear: both;"></div> | <div style="clear: both;"></div> | ||
Revision as of 20:24, 3 October 2013
<body>
To defeat tuberculosis, we need new biotechnology. Our work will add 4 new tools to the anti-TB medical armamentarium. Detect - A CRISPR-based biosensor delivered by phage and sequence-specific for antibiotic resistance. Target - An E. coli model hosting an essential mycobacterial metabolic pathway that could simplfy drug screening. Infiltrate - A E. coli strain capable of entering infected macrophages and lysing mycobacteria. Sabotage - A non-lytic phage that spreads horizontally in a bacterial population and expresses an siRNA to knock down antibiotic resistance.
Infiltrate
A more efficient treatment of TB should contain a drug which rapidly kills mycobacteria and a delivery system for such drug, which could enable the killing of mycobacteria inside the infected macrophages. In our system the rapid drug is Trehalose Dimycolate Hydrolase (TDMH), while the delivery system is LLO carrying strain of E. coli.
+33 1 44 41 25 22/25
team2013@igem-paris.org 
